Who backs Enterome?
18 investors| Investor | Type |
|---|---|
| Omnes Capital | PE / buyout |
| Bristol-Myers Squibb | — |
| Primo Capital (Milano) | Venture capital |
| Takeda Ventures | Venture capital |
| Nestlé Health Science | Other |
| Danone | — |
| Genopole | — |
| INRAE (France) | — |
| Institute for Follicular Lymphoma Innovation | — |
| Leukemia & Lymphoma Society | — |
| + 8 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Enterome investors
18 investors are on record for Enterome, including Omnes Capital, Bristol-Myers Squibb, Primo Capital (Milano) and Takeda Ventures.
Free account
More of Enterome with a free account
- ·The complete investor list: 18 names
- ·Watch Enterome: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 18 firms already write checks for companies like Enterome. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View